Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

American Journal of Gastroenterology

Volumn 107, Issue 5, 2012, Pages 761-767

  Hamilton, Matthew J ^a   Weingarden, Alexa R ^a   Sadowsky, Michael J ^a   Khoruts, Alexander ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DONOR; DONOR SELECTION; ENDOSCOPY; ENTERITIS; FECES MICROFLORA; FEMALE; FROZEN SECTION; HUMAN; LABORATORY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; SCREENING; STANDARDIZATION; VOLUNTEER; CLOSTRIDIUM DIFFICILE; COLON; FECES; FREEZING; MICROBIOLOGY; MIDDLE AGED; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE;

CLOSTRIDIUM DIFFICILE; COLON; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; FREEZING; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RECURRENCE; TISSUE DONORS;

EID: 84862309942     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.482     Document Type: Article

References (30)

1. Freeman J, Bauer MP, Baines SD et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23:529-49.
2. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med 2008;359:1932-40.
3. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-15.
4. Jarvis WR, Schlosser J, Jarvis AA et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009;37:263-70.
5. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16:604-9.
6. Ricciardi R, Rothenberger DA, Madoff RD et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624-31;discussion 631.
7. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14:929-31. (Pubitemid 351838602)
8. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7:526-36.
9. Kuijper EJ, Barbut F, Brazier JS et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008;13.
10. Surawicz CM. Reining in recurrent Clostridium difficile infection - who's at risk? Gastroenterology 2009;136:1152-4.
11. Louie TJ, Miller MA, Mullane KM et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011;364:422-31.
12. Pepin J, Routhier S, Gagnon S et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006;42:758-64. (Pubitemid 43363928)
13. Garey KW, Sethi S, Yadav Y et al. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008;70:298-304.
14. Hu MY, Katchar K, Kyne L et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009;136:1206-14.
15. Issa M, Vijayapal A, Graham MB et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345-51. (Pubitemid 46401531)
16. Rodemann JF, Dubberke ER, Reske KA et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339-44. (Pubitemid 46401530)
17. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1432-42.
18. Chang JY, Antonopoulos DA, Kalra A et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197:435-8. (Pubitemid 351263426)
19. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75. (Pubitemid 34761404)
20. Johnson S, Schriever C, Galang M et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007;44:846-8. (Pubitemid 46365312)
21. Johnson S, Schriever C, Patel U et al. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Anaerobe 2009;15:290-1.
22. Khoruts A, Dicksved J, Jansson JK et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010;44:354-60.
23. Eiseman B, Silen W, Bascom GS e t al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854-9.
24. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009;15:285-9.
25. van Nood E, Speelman P, Kuijper EJ et al. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 2009;14.
26. Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 2011;4:4-7.
27. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989;1:164. (Pubitemid 19034066)
28. Borody TJ, Warren EF, Leis S et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003;37:42-7. (Pubitemid 36734332)
29. Andrews PJ, Borody TJ. Putting back the bugs: bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Aust 1993;159:633-4. (Pubitemid 23322550)
30. Vrieze A, Holleman F, Zoetendal EG et al. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010;53:606-13.